Bromley, United Kingdom

Gareth Wilson

This inventor holds 1 USPTO granted patent. Top assignee: Natera, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gareth Wilson. Retrieved from https://idiyas.com/inventor/gareth-wilson-7ij89uu3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gareth Wilson - Innovator in Lung Cancer Detection

Introduction

Gareth Wilson is a notable inventor based in Bromley, GB. He has made significant contributions to the field of medical diagnostics, particularly in the detection of lung cancer. His innovative work focuses on improving methods for identifying genetic variants associated with this disease.

Latest Patents

Gareth holds a patent for "Methods for lung cancer detection." This invention provides methods for detecting single nucleotide variants in lung cancer, especially in cases of stage 3a lung adenocarcinoma and lung squamous cell carcinoma. The patent also includes additional methods and compositions, such as reaction mixtures and solid supports comprising clonal populations of nucleic acids.

Career Highlights

Gareth is currently employed at Natera, Inc., where he continues to advance his research in cancer detection technologies. His work is pivotal in enhancing the accuracy and efficiency of lung cancer diagnostics.

Collaborations

Gareth collaborates with esteemed colleagues, including Bernhard Zimmermann and Tudor Pompiliu Constantin. Their combined expertise contributes to the development of innovative solutions in the medical field.

Conclusion

Gareth Wilson's contributions to lung cancer detection exemplify the impact of innovation in healthcare. His work not only advances scientific understanding but also holds the potential to improve patient outcomes significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…